Luyan Pharma Co Ltd (002788) - Total Assets
Based on the latest financial reports, Luyan Pharma Co Ltd (002788) holds total assets worth CN¥13.04 Billion CNY (≈ $1.91 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Luyan Pharma Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Luyan Pharma Co Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Luyan Pharma Co Ltd's total assets have evolved over time, based on quarterly financial data.
Luyan Pharma Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Luyan Pharma Co Ltd's total assets of CN¥13.04 Billion consist of 78.1% current assets and 21.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 4.6% |
| Accounts Receivable | CN¥6.06 Billion | 47.9% |
| Inventory | CN¥2.86 Billion | 22.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥361.09 Million | 2.9% |
| Goodwill | CN¥289.28 Million | 2.3% |
Asset Composition Trend (2011–2024)
This chart illustrates how Luyan Pharma Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Luyan Pharma Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Luyan Pharma Co Ltd's current assets represent 78.1% of total assets in 2024, a decrease from 92.9% in 2011.
- Cash Position: Cash and equivalents constituted 4.6% of total assets in 2024, down from 12.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 47.9% of total assets.
Luyan Pharma Co Ltd Competitors by Total Assets
Key competitors of Luyan Pharma Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.47 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.27 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.93 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$346.42 Million |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥20.34 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
Luyan Pharma Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 1.15 | 1.22 |
| Quick Ratio | 0.80 | 0.83 | 0.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥917.19 Million | CN¥1.30 Billion | CN¥1.28 Billion |
Luyan Pharma Co Ltd - Advanced Valuation Insights
This section examines the relationship between Luyan Pharma Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.84 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | CN¥12.64 Billion |
| Market Capitalization | $776.60 Million USD |
Valuation Analysis
Below Book Valuation: The market values Luyan Pharma Co Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Luyan Pharma Co Ltd's assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Luyan Pharma Co Ltd (2011–2024)
The table below shows the annual total assets of Luyan Pharma Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥12.64 Billion ≈ $1.85 Billion |
+7.16% |
| 2023-12-31 | CN¥11.79 Billion ≈ $1.73 Billion |
+0.08% |
| 2022-12-31 | CN¥11.78 Billion ≈ $1.72 Billion |
+17.92% |
| 2021-12-31 | CN¥9.99 Billion ≈ $1.46 Billion |
+18.47% |
| 2020-12-31 | CN¥8.43 Billion ≈ $1.23 Billion |
+11.90% |
| 2019-12-31 | CN¥7.54 Billion ≈ $1.10 Billion |
+24.17% |
| 2018-12-31 | CN¥6.07 Billion ≈ $888.31 Million |
+18.28% |
| 2017-12-31 | CN¥5.13 Billion ≈ $751.03 Million |
+46.16% |
| 2016-12-31 | CN¥3.51 Billion ≈ $513.84 Million |
+2.40% |
| 2015-12-31 | CN¥3.43 Billion ≈ $501.77 Million |
+3.47% |
| 2014-12-31 | CN¥3.31 Billion ≈ $484.94 Million |
+17.28% |
| 2013-12-31 | CN¥2.83 Billion ≈ $413.48 Million |
+27.03% |
| 2012-12-31 | CN¥2.22 Billion ≈ $325.50 Million |
+67.49% |
| 2011-12-31 | CN¥1.33 Billion ≈ $194.34 Million |
-- |
About Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more